Loading...
XSHE002082
Market cap528mUSD
Jan 10, Last price  
6.34CNY
1D
-3.35%
1Q
37.83%
IPO
-30.18%
Name

Wepon Pharmaceutical Holding Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002082 chart
P/E
78.81
P/S
2.52
EPS
0.08
Div Yield, %
3.15%
Shrs. gr., 5y
20.69%
Rev. gr., 5y
-35.98%
Revenues
1.54b
-13.69%
535,416,4731,172,649,9013,738,956,3484,891,602,0035,835,868,4796,347,707,4308,053,707,36010,873,866,11210,972,922,38011,786,336,48811,451,694,09311,572,197,7729,183,466,30714,635,458,22314,335,310,46815,794,900,82113,701,855,5831,930,601,8661,786,428,3081,541,938,584
Net income
49m
-33.79%
25,674,43121,383,38632,849,65963,613,86774,047,353121,048,269151,985,726158,644,10586,409,313111,557,566107,530,80863,024,59769,735,58898,213,44884,080,466157,029,488284,935,733166,509,67774,322,52749,208,883
CFO
-73m
32,690,62211,227,3923,500,56612,453,463253,062,50668,134,391162,264,5910202,732,245234,352,539140,310,21416,762,923310,712,8490135,396,1000151,006,12022,085,1880-72,869,795
Dividend
Jul 11, 20240.08 CNY/sh
Earnings
May 16, 2025

Profile

Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research, development, production, and sale of Chinese medicines, APIs, and preparations. It also develops medical devices, including orthopaedic implant devices, medical equipment, and protective equipment, as well as disposable bacteria medical polymer consumables; and provides hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020. Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is based in Taizhou, China.
URL
https://www.dongliang.com.cn/
IPO date
Nov 20, 2006
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,541,939
-13.69%
1,786,428
-7.47%
Cost of revenue
1,299,221
1,357,720
Unusual Expense (Income)
NOPBT
242,717
428,708
NOPBT Margin
15.74%
24.00%
Operating Taxes
3,605
25,810
Tax Rate
1.49%
6.02%
NOPAT
239,112
402,898
Net income
49,209
-33.79%
74,323
-55.36%
Dividends
(122,028)
Dividend yield
3.10%
Proceeds from repurchase of equity
(1)
BB yield
0.00%
Debt
Debt current
824,312
714,382
Long-term debt
105,483
162,058
Deferred revenue
70,540
68,058
Other long-term liabilities
76,450
6,484
Net debt
703,186
389,901
Cash flow
Cash from operating activities
(72,870)
CAPEX
(128,724)
Cash from investing activities
(156,033)
Cash from financing activities
9,256
FCF
77,184
(130,553)
Balance
Cash
226,608
467,619
Long term investments
6
18,921
Excess cash
149,511
397,218
Stockholders' equity
2,368,708
2,587,709
Invested Capital
3,603,717
3,301,319
ROIC
6.93%
13.75%
ROCE
6.40%
11.48%
EV
Common stock shares outstanding
615,111
613,223
Price
6.40
-27.44%
8.82
-40.37%
Market cap
3,936,711
-27.21%
5,408,625
-40.70%
EV
4,741,177
5,929,547
EBITDA
339,654
535,742
EV/EBITDA
13.96
11.07
Interest
47,889
33,197
Interest/NOPBT
19.73%
7.74%